Buscar por Autor Pelegrin, Pablo

Ir a una fecha de inicio:
Mostrando resultados 1 a 14 de 14
Vista previaFecha de publicaciónFecha de CreaciónTítulo
2001 Cytokine fish IL-1.pdf.jpg2001-Interleukin-1β isolated from a marine fish reveals up-regulated expression in macrophages following activation with lipopolysaccharide and lymphokines
2004 Cell Tiss Res.pdf.jpg2004-Acidophilic granulocytes of the marine fish gilthead seabream (Sparus aurata L.) produce interleukin-1b following infection with Vibrio anguillarum
2004 CMLS.pdf.jpg2004-The tumor necrosis factor a of the bony fish seabream exhibits the in vivo proinflammatory and proliferative activities of its mammalian counterparts, yet it functions in a species-specific manner
2006 BJP P2X7 T283.pdf.jpg2006-Identification of Thr283 as a key determinant of P2X7 receptor function
2006 EMBO J Panx.pdf.jpg2006-Pannexin-1 mediates large pore formation and interleukin-1ß release by the ATP-gated P2X7 receptor
2007 MolPharm.pdf.jpg2007-Amino acid residues in the P2X7 receptor that mediate differential sensitivity to ATP and BzATP
2007 JCB.pdf.jpg2007-Pannexin-1 couples to maitotoxin and nigericin- induced il-1β release through a dye-uptake independent pathway
2008 JI.pdf.jpg2008-P2X7 receptor differentially couples to distinct release pathways for IL-1b in mouse macrophage
2009 EMBO J.pdf.jpg2009-Dynamics of macrophage polarization reveal new mechanism to inhibit IL-1beta release through pyrophosphates
2011 J Immunol.pdf.jpg2011-P2X7 Receptor-Dependent Intestinal Afferent Hypersensitivity in a Mouse Model of Postinfectious Irritable Bowel Syndrome
2012 J Immunol BRET.pdf.jpg2012-A genetically encoded IL-1β BRET sensor to monitor inflammasome activity
suppl 2016 Nat Immunol.pdf.jpg2016-Mitochondrial respiratory-chain adaptations in macrophages contribute to antibacterial host defense
2017 JMedChem.pdf.jpg2017-Development of an Acrylate Derivative Targeting the NLRP3 Inflam- masome for the Treatment of Inflammatory Bowel Disease
suppl 2018 Nat Comm.pdf.jpg2018-NLRP3 lacking the leucine-rich repeat domain can be fully activated via the canonical inflammasome pathway